Pharmacological treatment of atrial fibrillation;Traitement pharmacologique de la fibrillation auriculaire

Archives des Maladies du Coeur et des Vaisseaux

Volumn 90, Issue SPEC. ISS. I, 1997, Pages 41-46

  Leenhardt, A ^a   Thomas, O ^a   Coumel, P ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; FLECAINIDE; PROPAFENONE; QUINIDINE; SOTALOL; VERAPAMIL;

CARDIOVERSION; CONFERENCE PAPER; ELECTROPHYSIOLOGY; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION;

ADRENERGIC BETA-ANTAGONISTS; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIA; ATRIAL FIBRILLATION; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FLECAINIDE; HUMANS; RECURRENCE;

EID: 0030916836     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (28)

1. Nattel S. Newer developments In the management of atrial fibrillation. Am Heart J 1995 ; 130 : 1094-106.
2. Prystowsky EN, Benson W, Fuster V et al. Managements of patients with atrial fibrillation. A statement of healthcare professionals from the subcommittee on electrocardiography and electrophysiology, American Heart Association. Circulation 1996 ; 93 : 1262-77.
3. Coumel P, Thomas O, Leenhardt A. Drug therapy for prevention of atrial fibrillation. Am J Cardiol 1996 ; 77 : A 3-A 9.
4. Lévy S, Novella P, Ricard P, Paganelli F. Paroxysmal atrial fibrillation : a need for classification. J Cardiovasc Electrophysiol 1995 ; 6 : 69-74.
5. Sopher SM, Camm AJ. Atrial fibrillation : maintenance of sinus rhythm versus rate control. Am J Cardiol 1996 ; 77 : A 24-A 37.
6. Allessie MA, Konings K, Kirchhof C.J.H.J., Wijffels M. Electrophysiologic mechanisms of perpetuation of atrial fibrillation. Am J Cardiol 1996 ; 77 : A10-A 23.
7. Rensma PL, Allessie MA, Lammers WJEP, Bonke FM, Schalij MJ. Length of excitation wave and susceptibility to reentrant atrial arrhythmias in normal conscious dogs. Circ Res 1990 ; 62 : 395-410.
8. Carson PE, Johnson GR, Dunkman WB, Fletcher RD, Farrell L, Cohn J. The influence of atrial fibrillation on prognosis in mild to moderate heart failure. The V-HeFT studies. The V- HeFT VA cooperative studies group. Circulation 1993 ; 87 : 102-10.
9. Page RL, Wilkinson WE, Clair WK, McCarthy EA, Pritchett ELC. Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. Circulation 1994 ; 89 : 224-7.
10. Escoubet B, Poirier JM, Maison Blanche P et al. Effets antiarythmiques de l'amiodarone dons les 24 heures suivant une dose de charge orale unique. Arch Mal Cœur 1985 ; 7 : 1046-52.
11. Capucci A, Boriani G, Botto GL et al. Conversion of recent-onset atrial fibrillation by a single oral loading dose of propafenone or flecainide. Am J Cardiol 1994 ; 74 : 503-5.
12. Wang ZG, Pelletier LC, Tralajic M, Nattel S. Effects of flecainide and quinidine on human atrial action potentials. Role of rate-dependence and comparison with guinea pig, rabbit, and dog tissues. Circulation 1990 ; 82 : 274-83.
13. Coumel Ph. Neural aspects of paroxysmal atrial fibrillation. In : Folk RH, Podrid PJ, (eds). Atrial fibrillation : mechanisms and management. New York : Raven Press Ltd, 1992 : 109-25.
14. Murgatroyd FD, Camm AJ. Sinus rhythm, the autonomic nervous system, and quality of life. In : Kingma JH, Van Hemel NM, Lie KI (eds). Atrial fibrillation, a treatable disease ? Dordrecht, The Netherlands. Kluwer Acad Publ, 1992 : 195-210.
15. Coumel P, Escoubet B, Attuel P. Beta-blocking therapy in atrial and ventricular tachyarrhythmias. Experience with nadolol. Am Heart J 1984 ; 108 : 1098-108.
16. Crijns HJGM, Gosselink ATM, Van Gelder IC et al. Drugs after cardioversion to prevent relapses of chronic atrial fibrillation or flutter. In : Kingma JH, Van Hemel NM, Lie KI (eds). Atrial fibrillation, a treatable disease ? Dordrecht, The Netherlands. Kluwer Acad Publ, 1992 : 105-43.
17. Fuchs T, Podrid P. Pharmacologic therapy for reversion of atrial fibrillation and maintenance or sinus rhythm. In : « Atrial fibrillation : mechanisms and management » Kalk RH & Prodrid PJ eds, New York : Raven Press Publ, 1992 : 233-54.
18. UK Propafenone PSVT Study Group. A randomized, placebocontrolled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation. Circulation 1995 ; 92 : 2550-7.
19. Chun SH, Sager PT, Stevenson WG, Nademanee K, Middlekauff HR, Singh BN. Long-term efficacy of amiodarone for the maintenance of normal sinus rhythm in patients with refractory atrial fibrillation or flutter. Am J Cardiol 1995 ; 76 : 47-50.
20. Allot E, Denjoy I and the Flecainide AF French Study Group. Comparison of the safety and efficacy of flecainide versus propafenone in Hospital out-patients with symptomatic paroxysmal atrial fibrillation/flutter. Am J Cardiol 1996 ; 77 : A 66-A 71.
21. Reimold SC, Chalmers TC, Berlin JA, Antman EM. Assessment of the efficacy and safety of antiarrhythmic therapy for chronic atrial fibrillation : observations on the role of trial design and implication of drug-related mortality. Am Heart J 1992 ; 124 : 924-32.
22. Coplen SE, Antmann EM, Berlin JA, Hewitt P, Chalmers TC. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials. Circulation 1990 ; 82 : 1106-16.
23. Södermark T, Edhag O, Sjögren A et al. Effect of quinidine on maintaining sinus rhythm after conversion of atrial fibrillation or flutter. A multicenter study from Stockholm. Br Heart J 1975 ; 37 : 86-92.
24. Flaker GC, Blachshear JL, McBride R, Kronmal RA, Halperin JL, Hart RG. Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. J Am Coll Cardiol 1992 ; 20 : 427-32.
25. Coumel P, Fayn J, Maison-Blanche P, Rubel P. Clinical relevance of assessing QT dynamicity in Holter recordings. J Electrocardiol 1994 ; 27 : 62-6.
26. Juul-Möller S, Edvardsson N, Rehnqvist-Ahlberg N. Sotalol versus quinidine for the maintenance of sinus rhythm after direct current conversion of atrial fibrillation. Circulation 1990 ; 82 : 1932-9.
27. Asano Y, Saito J, Matsumoto K, Kaneko K, Yamamoto T, Masatsugu U. On the mechanism of termination and perpetuation of atrial fibrillation. Am J Cardiol 1992 ; 69 : 1033-8.
28. Capucci A, Biffi M, Boriani G et al. Dynamic electrophysiological behavior of human atria during paroxysmal atrial fibrillation. Circulation 1995 ; 92 : 1193-202.